INTRODUCTION
Noroviruses (NoV) belong to the Caliciviridae family, within which the NoV genus consists of five main genogroups, each of which can be further subdivided into genoclusters. Three NoV genogroups (GI, GII, GIV) are known to infect humans ; however, most of contemporary NoV outbreaks, and sporadic cases, of gastroenteritis worldwide are caused by GII genotypes, in particular genocluster 4 (GII.4) [1] . In the past 15 years, several distinct variants of GII. 4 have emerged every few years causing five pandemics of gastroenteritis [2] [3] [4] . Most notable recently was the simultaneous emergence of NoV variants GII.4 2006a and 2006b, both of which were first reported in Europe and have subsequently spread to many countries [5] . Initially NoV variant GII.4 2006a was the predominant strain in most areas with the exclusion of Asia, where this variant has been rarely detected [1, [5] [6] [7] [8] . Following which, NoV variant GII.4 2006b quickly replaced 2006a as the dominant strain with a global distribution [1, 8] . Over time, epidemic waves of GII.4 viruses have been getting closer together, with pandemic strains being replaced by a new dominant strain every 1-2 years [3] .
The emergence of new strains is associated with increased incidence of infection and an increase in out-of-season (April-September) outbreaks [9] . Such outbreaks of NoV gastroenteritis are a major problem in healthcare facilities as they most often result in ward closures [10] . In Scotland, due to the lack of a national NoV genotyping programme, there is limited data on the molecular epidemiology of NoV. An increase in NoV infections due to NoV variant GII.4 2006a was reported in Scotland in 2006 [11, 12] . Recent years have seen an increase in the number of laboratory-confirmed NoV outbreaks in Edinburgh healthcare institutions. To determine the NoV variants associated with these outbreaks, sequence analysis of the capsid gene and the adjacent region of orf1 was performed for a representative number of NoV outbreaks in samples collected from Edinburgh healthcare facilities between 1 June 2008 and 31 July 2011. In addition to determining the genotypes responsible for NoV outbreaks, we also investigated the temporal occurrence of the genotypes to enable a better understanding of the epidemiology of the outbreaks.
METHODS

Samples
A total of 1871 samples that had previously been confirmed as positive for NoV GII RNA by reverse transcription-polymerase chain reaction (RT-PCR) during routine diagnostic testing were used as the pool to select the representative samples for sequence analysis. The samples were selected so as to be representative of the temporal patterns in observed clusters of outbreaks and from sporadic cases in healthcare institutions. An outbreak of gastroenteritis was defined as two or more cases in a ward with dates of onset within 7 days of each other. An outbreak was considered to be caused by NoV if two or more cases with gastrointestinal illness met the Kaplan criteria [13] after assessment of the situation by the infection control team. In some outbreaks only one sample was submitted for NoV detection by real-time PCR.
Between one and four samples, previously confirmed as being NoV GII positive, from each outbreak were sequenced.
Nested RT-PCR (nPCR)
Reverse transcription and first-round RT-PCR was performed using the Qiagen One-Step RT-PCR kit (Qiagen, UK). Briefly, 25 ml reactions contained 1r One Step RT-PCR buffer, 0 . 4 mM dNTPs ; 0 . 6 mM each outer primer [14] (Eurogentecs, Belgium); 1 ml enzyme mix ; and 10 ml RNA extract. RT was performed at 50 xC for 30 min, followed by PCR amplification: 95 xC for 15 min followed by 25 cycles at 94 xC for 30 s, 55 xC for 30 s, and 72 xC for 60 s. Secondround PCR was performed in 50 ml reactions with 1x HotStart PCR Mastermix (Qiagen) ; 0 . 6 mM each inner primer [14] (Eurogentecs) ; and 5 ml of either neat or 1/10 diluted first-round product. PCR was performed at 95 xC for 15 min followed by 35 cycles at 94 xC for 30 s, 60 xC for 30 s, and 72 xC for 60 s. A final extension step of 72 xC for 10 min was performed on the GeneAmp 1 PCR System 7500 (Applied Biosystems, UK).
Region amplified
The primers NV2oF2 and NV2oR amplified a 378-bp fragment encompassing 55 bp at the 3k end of the RNA-dependent RNA polymerase gene and 344 bp at the 5k end of the major capsid gene. Primers G2F3 and G2SKR amplified a 311-bp fragment within this region [14] .
DNA Sequencing and phylogenetic analysis
PCR products were purified using Exosap-IT (GE Healthcare UK Ltd, UK). Cleaned products were sequenced using the BigDye Terminator v.3.1 Cycle Sequencing kit on an ABI 3130xl Genetic Analyser (Applied Biosystems, UK). Sequences were aligned and analysed using Bionumerics software version 5.1 (Applied Maths, Belgium), and database searches for related sequences were conducted using BLAST. The sequenced isolates were designated as being a new strain based on analysis of point mutations across a 270-bp region at the 5k end of the capsid gene when compared to the predominant circulating NoV variant group. The new strains were designated v1, v2, v3, etc. based on the time sequence of their emergence.
A phylogenetic dendogram was generated by using the neighbour-joining method with unweighted pairgroup method using arithmetic averages (UPGMA). Reference strains included: AB434770 OC07138, DQ676865 Lincoln House 2006b, DQ665819 Rhyl440/ 2005/UK 2006a, X86557 Lordsdale Bristol variant, AJ004864 Grimsby USA95/96 and HQ230937 New Orleans 2010. To determine how well the phylogenetic trees were supported by the data bootstrap analysis (100 iterations of the alignments) were performed using Bionumerics.
RESULTS
In order to investigate the molecular epidemiology behind the NoV outbreaks, 287 of the 1871 (15 . 3%) NoV-positive specimens submitted to the laboratory during this period were sequenced. NoV was successfully amplified and sequenced from a representative number of cases in outbreaks (n=268) and from sporadic cases (n=19). This represents a minimum of one NoV successfully sequenced from 134 (38 %) of the 355 confirmed NoV-positive outbreaks between July 2008 and June 2011 (Table 1) .
Phylogenetic analysis of the nRT-PCR products identified 69 strains belonging to six different GII genoclusters (GII.1, GII.2, GII.3, GII.4, GII.6, GII.13). Overall, the predominant genotype was GII. 4 Of the four non-GII.4 clusters, a single GII.1 strain and two closely related GII.2 and GII.3 strains were identified. One GII.6 strain was isolated from a sporadic case of gastroenteritis in a hospital patient. The majority (70 %) of sequenced outbreaks in this time period were due to NoV variant isolates that differed from each other by either one (v2, v12, v18, v21), two (v1, v3, v4, v5, v6, v8, v9, v13, v19), three (v7, v11, v16, v17, v22) or four nucleotides (v10, v14, v15, v20) compared to the reference strain. Sequencing of isolates showed that the majority of outbreaks were due to one strain of the GII.4 2010 variant (v1), which was isolated from 36% of the typed outbreaks that season, predominantly between November 2009 and January 2010. Of the non-GII.4 genotypes, the GII.3 cluster consisted of five strains that differed from each other by either one, three, four or five nucleotides. Together they were responsible for 3% of outbreaks. GII.1 was found between April and May 2010 and caused two outbreaks, 3% of the total. The GII.13 (HuIVi668/ 06/IND) genotype was the aetiological agent in 7 % of outbreaks appearing in the first quarter of 2010.
In the most recent NoV season, July 2010-June 2011, there were three NoV genoclusters circulating in Edinburgh, GII.1, GII.4 and GII.6. The GII.13 genotype was also isolated from a sporadic case in a children's hospital. Mainly, there were two GII. An analysis of the temporal distribution of the NoV outbreak strains showed the predominant strain changes over time (Fig. 2) . Three peaks in norovirus activity could be observed between July (Table 2) .
A range of specialities were affected by outbreaks across all years, although the majority were associated with medicine of the elderly (geriatric medicine). (v1, v3, v5, v7, v8, v25 ), GII.6 and GII.13. Almost half (7/19) of the sporadic infections occurred in children, and 10 % of the strains were not associated with outbreaks. Otherwise sporadic cases were caused by strains that were currently in circulation in the healthcare facilities (data not shown).
DISCUSSION
In total, 355 outbreaks of NoV gastroenteritis were reported between June 2008 and July 2011. Analysis of sequence data from the 5k end of the NoV capsid region for 38% of these outbreaks was successfully undertaken. Although this region is not the most heterogeneous part of the NoV genome, it was used to allow a conserved set of primers to enable the amplification of a wide range of GII genotypes. The genotyping rate using these primers for RT-PCR and sequencing was 73 %. This compares favourably with a multicentre study that reported a similar overall success rate (78 %) for NoV genotyping of the same region compared to 52% for the more variable region in orf2 [15] . A diverse range of GII genoclusters were identified in our study with GII.4 being the predominant genotype. This is consistent with other recent molecular epidemiological and surveillance studies that have found GII.4 to be responsible for the majority of NoV infections and outbreaks worldwide [1, 14, 16, 17] . Overall, in our study, there were 51 strains of NoV variant GII.4 detected, which were responsible for 88 % of outbreaks. A recent European study based on sequences submitted to the Food-Borne Viruses in Europe (FBVE) network reported that genogroup GII.4 was responsible for 87% of European outbreaks occurring between 2008 and mid-May 2011 [18] . [19] , and highly related to a strain reported in Japan [20] , Egypt [21] , France [7] , Belgium [22] and Canada [4] . Similar to our findings, Belliot et al. [2, 12, 28, 29] , this is a relatively conserved region of the NoV genome and it is unclear whether these point mutations result in a phenotypic change in these viruses. Analysis of the P2 region of the genome in the outbreak-associated variants we have detected can provide further information on the homologous nature of the virus genomes and the selective advantages that they hold. Selective advantages have been reported for viruses with nucleotide and amino-acid substitutions in these more variable, protruding regions of the capsid [30] . In particular, amino-acid changes in two exposed loops of the P2 domain have been shown to be responsible for virus escape mutants that have caused epidemics of gastroenteritis in the population [31, 32] .
We found that the NoV variants GII.4 2006 and 2010, responsible for large increases in NoV gastroenteritis outbreaks, were circulating in Lothian healthcare facilities for at least 2-4 weeks preceding the peak of their activity, both the NoV variant GII.4 2006b v3 and v8 strains initially emerged in the season prior to their epidemic peaks. Gallimore et al. have reported that there is a greater mix of strains circulating at the start of the season compared to the end [28] . An active surveillance system could allow for the identification of variants that could become epidemic strains and certainly strains known to be associated with outbreaks elsewhere in the world.
The study also supports previous findings that, although NoV can infect all ages those most at risk are the elderly, the immunocompromised and young children. Outbreaks were more commonly associated with wards treating elderly patients and patients with immunosuppression, whereas, cases in children tended to be of a more sporadic nature. The average size of individual outbreaks in Edinburgh healthcare facilities may be decreasing over time, this trend appears to be independent of the overall severity of NoV infection in a season but may be inversely related to the length of ward closure. There may be additional infection control measures associated with this trend but there is need of a prospective analysis to ascertain the significance of this observation.
Additionally, the emergence of epidemic non-GII.4 strains has also been reported in recent literature. The winter of 2009/2010 saw the emergence of a GII.12 strain that was ultimately responsible for 16 % of outbreaks in the USA that year [33] . Prior to 1991 non-GII. 4 NoV strains had been shown to predominate [34] . Our study also found 14% of outbreaks in one season to be due to non-GII.4 genotypes. Most notable was the emergence of a GII.13 strain in January 2010 responsible for four outbreaks, 7 % of the total, in the first quarter of 2010.
The emergence of new recombinants has also been observed in recent years [7, 20, 22] . The ORF1-ORF2 overlap is known to be a hotspot for NoV recombination [13, 22, 35, 36] and further analysis upstream of this region may also provide additional information regarding the inclusion of recombinants in our isolates. Mathjis et al. have reported a number of novel norvirus recombinants isolated from foodborne outbreaks of gastroenteritis in Belgium in recent years [22] , and it is unclear what significance these strains may play in the healthcare setting.
In conclusion, NoV outbreaks are a considerable burden in the NHS causing multiple ward closures, loss of resources, morbidity and possibly mortality in vulnerable populations. The present study revealed strains of genotype GII.4 2006b as the most recent predominant circulating variant in Edinburgh. The emergence of two new GII.4 strains, GII.4 2007 and GII.4 2010, was also detected. An important finding of this study was that outbreaks were linked to emergence of particularly successful variants of GII.4 strains. Although the reason for this is unknown it highlights the need for an active worldwide surveillance system to alert infection control teams to the detection of new and emerging strains and the need for further research into predictors of outbreak capacity in emerging variants.
